Hourglass Capital LLC Has $7.30 Million Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Hourglass Capital LLC reduced its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 0.4% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 22,707 shares of the company’s stock after selling 95 shares during the quarter. HCA Healthcare accounts for about 2.2% of Hourglass Capital LLC’s investment portfolio, making the stock its 12th largest holding. Hourglass Capital LLC’s holdings in HCA Healthcare were worth $7,295,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of the business. Waverton Investment Management Ltd raised its stake in shares of HCA Healthcare by 10.5% in the 2nd quarter. Waverton Investment Management Ltd now owns 141,414 shares of the company’s stock valued at $45,424,000 after purchasing an additional 13,448 shares during the period. Kornitzer Capital Management Inc. KS lifted its stake in HCA Healthcare by 0.7% in the 2nd quarter. Kornitzer Capital Management Inc. KS now owns 8,225 shares of the company’s stock valued at $2,643,000 after acquiring an additional 55 shares in the last quarter. National Bank of Canada FI grew its stake in shares of HCA Healthcare by 9.9% during the 2nd quarter. National Bank of Canada FI now owns 101,585 shares of the company’s stock worth $32,001,000 after acquiring an additional 9,163 shares in the last quarter. TD Asset Management Inc lifted its position in shares of HCA Healthcare by 2.7% in the second quarter. TD Asset Management Inc now owns 741,130 shares of the company’s stock worth $238,110,000 after purchasing an additional 19,812 shares in the last quarter. Finally, Cooke & Bieler LP increased its stake in HCA Healthcare by 9.8% in the 2nd quarter. Cooke & Bieler LP now owns 215,748 shares of the company’s stock valued at $69,316,000 after buying an additional 19,217 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Insider Activity at HCA Healthcare

In other news, SVP Kathryn A. Torres sold 1,857 shares of the stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the transaction, the senior vice president now directly owns 17,755 shares in the company, valued at approximately $6,303,912.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, SVP Kathryn A. Torres sold 1,857 shares of the firm’s stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the transaction, the senior vice president now owns 17,755 shares in the company, valued at approximately $6,303,912.75. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction that occurred on Monday, July 29th. The stock was sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the sale, the senior vice president now directly owns 40,449 shares in the company, valued at $14,569,729.80. The disclosure for this sale can be found here. Insiders sold a total of 8,844 shares of company stock valued at $3,185,932 in the last quarter. Insiders own 1.60% of the company’s stock.

Wall Street Analysts Forecast Growth

HCA has been the topic of a number of recent research reports. Deutsche Bank Aktiengesellschaft lifted their target price on HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a research report on Friday, June 28th. Oppenheimer upped their price objective on HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 24th. Truist Financial boosted their target price on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, August 19th. JPMorgan Chase & Co. boosted their price objective on shares of HCA Healthcare from $327.00 to $332.00 and gave the stock a “neutral” rating in a research note on Thursday, May 30th. Finally, Wolfe Research raised HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. Five equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and three have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $359.89.

HCA Healthcare Trading Up 0.9 %

Shares of HCA stock opened at $401.36 on Friday. The stock has a 50 day simple moving average of $354.09 and a 200 day simple moving average of $335.48. HCA Healthcare, Inc. has a 1 year low of $215.96 and a 1 year high of $401.87. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The stock has a market cap of $105.12 billion, a P/E ratio of 19.83, a price-to-earnings-growth ratio of 1.52 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The firm had revenue of $17.49 billion for the quarter, compared to the consensus estimate of $17.05 billion. During the same period in the prior year, the company posted $4.29 earnings per share. The business’s revenue for the quarter was up 10.3% on a year-over-year basis. On average, research analysts predict that HCA Healthcare, Inc. will post 22.5 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be paid a $0.66 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.66%. HCA Healthcare’s payout ratio is currently 13.16%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.